Literature DB >> 32044391

Sex difference in the association of APOE4 with cerebral glucose metabolism in older adults reporting significant memory concern.

Lingxiang Jiang1, Hui Lin2, Yide Chen3.   

Abstract

There is accumulating evidence that the association of apolipoprotein E4 (APOE4) with the risk of developing Alzheimer's disease (AD) is modified by sex. However, the associations of APOE4 status and sex with AD-related markers in older adults with significant memory concern (SMC) remain elusive. Among individuals with SMC (n = 106), we investigated the associations of APOE4 status and sex with multiple AD-related markers, including verbal memory, hippocampal volumes, cerebral glucose metabolism and cortical amyloid burden. In individuals with SMC, we found a significant APOE4*sex interaction for cerebral glucose metabolism, but not verbal memory, hippocampal volumes or cortical amyloid burden. Specifically, female APOE4 carriers showed significantly higher cerebral glucose metabolism compared to female APOE4 non-carriers whereas male APOE4 carriers had lower cerebral glucose metabolism than male APOE4-noncarriers. In conclusion, the effect of APOE4 on cerebral glucose metabolism is altered by sex in individuals with SMC.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Apolipoprotein E; Cerebral glucose metabolism; FDG-PET; Sex differences; Significant memory concern

Mesh:

Substances:

Year:  2020        PMID: 32044391     DOI: 10.1016/j.neulet.2020.134824

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  2 in total

1.  N6-methyladenine-modified DNA was decreased in Alzheimer's disease patients.

Authors:  Shuang Lv; Xiao Zhou; Yi-Ming Li; Tao Yang; Shu-Juan Zhang; Yu Wang; Shu-Hong Jia; Dan-Tao Peng
Journal:  World J Clin Cases       Date:  2022-01-14       Impact factor: 1.337

Review 2.  Altered substrate metabolism in neurodegenerative disease: new insights from metabolic imaging.

Authors:  Nicholas R W Cleland; Saif I Al-Juboori; Evgenia Dobrinskikh; Kimberley D Bruce
Journal:  J Neuroinflammation       Date:  2021-10-28       Impact factor: 8.322

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.